Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Severstal supplies 90% of its products to the Russian market

9/8/23 CHMF

Gazprom will be a partner in the project to create Aurus-branded marine vessels

9/8/23 GAZP

Severstal has no plans to buy back shares from non-residents

9/8/23 CHMF

Nornickel has no plans to resume dividend payments for the time being

9/8/23 GMKN

Severstal expects in 2023 to produce 11.5 million tons of steel

9/8/23 CHMF

VK launched video advertising in SDEK delivery points

9/8/23 VKCO

The Verizon Communications announced a quarterly dividend

9/7/23 VZ

SUAL Partners asked the Moscow Exchange to check Rusal's compliance with the dividend policy

9/7/23 RUAL

Companies of Artgen Biotech Group intend to enter the markets of friendly countries

9/7/23 ABIO

Sistema will become the main investor in the SEZ in Mordovia

9/7/23 AFKS